fda statement bpc-157 compounding safety risks FDA's own advisory committee voted 8-6 Thursday. BPC-157, on the list now, for ulcerative colitis. staff argued against it, laid out the data gaps, the whole case. Panel overruled them Excellent news for us on

Excellent news for us on the frontiers of medicine. Bringing back peptides to compounding pharmacies is the long awaited expectation from this administration. I voted for this. In September 2023, the Biden FDA to review 7 popular peptides touted for weight loss, healing and longevity FDA panel narrowly backs unapproved peptide drug touted by Joe Rogan and other influencers Pittsburgh Post Gazette Federal health advisers are meeting to review a group of controversial chemicals called peptides, which have become a growing wellness trend. FULL STORY

SKU: 79076710858 · From iglepidom.org